LabStyle Innovations Announces Uplisting to NASDAQ and Capital Raise of $8.5 Million

LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective March 4, 2016, and will trade under the symbols "DRIO" and "DRIOW", respectively.The Company also announced the pricing of a firm commitment underwritten public offering of  1,333,333 shares of common stock  and warrants to purchase up to 1,333,333 shares for an approximate aggregate gross amount of $6.0 million as well as a concurrent private placement of common stock and warrants for an approximate aggregate gross amount of $2.5 million.